Why Moderna (MRNA) Stock Is Falling Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 6.9% in the afternoon session after ongoing concerns about its financial performance and a recent clinical setback overshadowed an announcement about a new, early-stage study. While Moderna announced it had dosed the first patient in a Phase 1/2 study for a multiple myeloma therapy, investors looked past this…
